BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27373156)

  • 1. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
    Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
    Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
    Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
    Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
    Denny SK; Yang D; Chuang CH; Brady JJ; Lim JS; Grüner BM; Chiou SH; Schep AN; Baral J; Hamard C; Antoine M; Wislez M; Kong CS; Connolly AJ; Park KS; Sage J; Greenleaf WJ; Winslow MM
    Cell; 2016 Jul; 166(2):328-342. PubMed ID: 27374332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.
    Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
    Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
    Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear factor I/B is an oncogene in small cell lung cancer.
    Dooley AL; Winslow MM; Chiang DY; Banerji S; Stransky N; Dayton TL; Snyder EL; Senna S; Whittaker CA; Bronson RT; Crowley D; Barretina J; Garraway L; Meyerson M; Jacks T
    Genes Dev; 2011 Jul; 25(14):1470-5. PubMed ID: 21764851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
    Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
    Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A
    Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
    Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
    Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crucial requirement for Hedgehog signaling in small cell lung cancer.
    Park KS; Martelotto LG; Peifer M; Sos ML; Karnezis AN; Mahjoub MR; Bernard K; Conklin JF; Szczepny A; Yuan J; Guo R; Ospina B; Falzon J; Bennett S; Brown TJ; Markovic A; Devereux WL; Ocasio CA; Chen JK; Stearns T; Thomas RK; Dorsch M; Buonamici S; Watkins DN; Peacock CD; Sage J
    Nat Med; 2011 Oct; 17(11):1504-8. PubMed ID: 21983857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
    Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
    Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.
    Meuwissen R; Linn SC; Linnoila RI; Zevenhoven J; Mooi WJ; Berns A
    Cancer Cell; 2003 Sep; 4(3):181-9. PubMed ID: 14522252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
    Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
    Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.
    Gao G; Hausmann S; Flores NM; Benitez AM; Shen J; Yang X; Person MD; Gayatri S; Cheng D; Lu Y; Liu B; Mazur PK; Bedford MT
    Nat Commun; 2023 Jan; 14(1):363. PubMed ID: 36690626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
    Borromeo MD; Savage TK; Kollipara RK; He M; Augustyn A; Osborne JK; Girard L; Minna JD; Gazdar AF; Cobb MH; Johnson JE
    Cell Rep; 2016 Aug; 16(5):1259-1272. PubMed ID: 27452466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.
    Sutherland KD; Proost N; Brouns I; Adriaensen D; Song JY; Berns A
    Cancer Cell; 2011 Jun; 19(6):754-64. PubMed ID: 21665149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.
    Chen KS; Bridges CR; Lynton Z; Lim JWC; Stringer BW; Rajagopal R; Wong KT; Ganesan D; Ariffin H; Day BW; Richards LJ; Bunt J
    J Neurooncol; 2020 Jan; 146(1):41-53. PubMed ID: 31760595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.
    Becker-Santos DD; Lonergan KM; Gronostajski RM; Lam WL
    EBioMedicine; 2017 Aug; 22():2-9. PubMed ID: 28596133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.